Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,001 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of sodium-glucose cotransporter 2 inhibitor in patients with non-alcoholic fatty liver disease and type 2 diabetes mellitus: a propensity score-matched analysis of real-world data.
Arai T, Atsukawa M, Tsubota A, Mikami S, Ono H, Kawano T, Yoshida Y, Tanabe T, Okubo T, Hayama K, Nakagawa-Iwashita A, Itokawa N, Kondo C, Kaneko K, Emoto N, Nagao M, Inagaki K, Fukuda I, Sugihara H, Iwakiri K. Arai T, et al. Among authors: nagao m. Ther Adv Endocrinol Metab. 2021 Mar 21;12:20420188211000243. doi: 10.1177/20420188211000243. eCollection 2021. Ther Adv Endocrinol Metab. 2021. PMID: 33815743 Free PMC article.
Liver fibrosis is associated with carotid atherosclerosis in patients with liver biopsy-proven nonalcoholic fatty liver disease.
Arai T, Atsukawa M, Tsubota A, Kato K, Abe H, Ono H, Kawano T, Yoshida Y, Tanabe T, Okubo T, Hayama K, Nakagawa-Iwashita A, Itokawa N, Kondo C, Kaneko K, Emoto N, Nagao M, Inagaki K, Fukuda I, Sugihara H, Iwakiri K. Arai T, et al. Among authors: nagao m. Sci Rep. 2021 Aug 5;11(1):15938. doi: 10.1038/s41598-021-95581-8. Sci Rep. 2021. PMID: 34354193 Free PMC article.
Antifibrotic effect and long-term outcome of SGLT2 inhibitors in patients with NAFLD complicated by diabetes mellitus.
Arai T, Atsukawa M, Tsubota A, Mikami S, Haruki U, Yoshikata K, Ono H, Kawano T, Yoshida Y, Tanabe T, Okubo T, Hayama K, Nakagawa-Iwashita A, Itokawa N, Kondo C, Kaneko K, Nagao M, Inagaki K, Fukuda I, Sugihara H, Iwakiri K. Arai T, et al. Among authors: nagao m. Hepatol Commun. 2022 Nov;6(11):3073-3082. doi: 10.1002/hep4.2069. Epub 2022 Aug 30. Hepatol Commun. 2022. PMID: 36039537 Free PMC article.
Comparison of three α-glucosidase inhibitors for glycemic control and bodyweight reduction in Japanese patients with obese type 2 diabetes.
Sugihara H, Nagao M, Harada T, Nakajima Y, Tanimura-Inagaki K, Okajima F, Tamura H, Inazawa T, Otonari T, Kawakami M, Oikawa S. Sugihara H, et al. Among authors: nagao m. J Diabetes Investig. 2014 Mar 23;5(2):206-12. doi: 10.1111/jdi.12135. Epub 2013 Oct 25. J Diabetes Investig. 2014. PMID: 24843762 Free PMC article.
Sitagliptin improves plasma apolipoprotein profile in type 2 diabetes: A randomized clinical trial of sitagliptin effect on lipid and glucose metabolism (SLIM) study.
Tanimura-Inagaki K, Nagao M, Harada T, Sugihara H, Moritani S, Sasaki J, Kono S, Oikawa S; SLIM Study Investigators. Tanimura-Inagaki K, et al. Among authors: nagao m. Diabetes Res Clin Pract. 2020 Apr;162:108119. doi: 10.1016/j.diabres.2020.108119. Epub 2020 Mar 17. Diabetes Res Clin Pract. 2020. PMID: 32194219 Clinical Trial.
Perioperative glycemic status is linked to postoperative complications in non-intensive care unit patients with type-2 diabetes: a retrospective study.
Oba T, Nagao M, Kobayashi S, Yamaguchi Y, Nagamine T, Tanimura-Inagaki K, Fukuda I, Sugihara H. Oba T, et al. Among authors: nagao m. Ther Adv Endocrinol Metab. 2022 May 19;13:20420188221099349. doi: 10.1177/20420188221099349. eCollection 2022. Ther Adv Endocrinol Metab. 2022. PMID: 35646304 Free PMC article.
2,001 results